Metraipolis › archive › dc_134eb2cd4c47

Efficacy of ChatGPT in personalized glucose-lowering strategy development: a clinician-based comparative study — Europe PMC PMID:41890178

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41890178
DOI
10.3389/fendo.2026.1693381
License (as archived)
solo-consultazione
Archived
2026-10-08T13:35:01.682Z
SHA-256 of the archived text
8643d2ab113a992a8e0688e8a785376ba0208846a950f43bfa3946e4460e7934
Stable URL of this page
https://metraipolis.com/documento/dc_134eb2cd4c47

How to cite

Efficacy of ChatGPT in personalized glucose-lowering strategy development: a clinician-based comparative study — Europe PMC PMID:41890178 — Europe PMC (en), https://europepmc.org/article/MED/41890178 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_134eb2cd4c47 (Metraipolis archive dc_134eb2cd4c47, sha256 8643d2ab113a992a8e0688e8a785376ba0208846a950f43bfa3946e4460e7934)
BibTeX
@misc{dc134eb2cd4c47,
  title = {Efficacy of ChatGPT in personalized glucose-lowering strategy development: a clinician-based comparative study — Europe PMC PMID:41890178},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41890178},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_134eb2cd4c47; sha256 8643d2ab113a992a8e0688e8a785376ba0208846a950f43bfa3946e4460e7934},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41890178. Agents can read the archived copy with the MCP tool read_document.